Roche Diagnostics CEO
This article was originally published in The Gray Sheet
Executive Summary
Martin Madaus, PhD, is slated to become president and CEO of Millipore Corp. by Feb. 1. The 45-year-old recently left Roche Diagnostics, which he led as president and chief exec since 2000. Heino von Prondzynski, head of Roche's diagnostics division in Basel, Switzerland, will assume operational oversight of the team until a permanent replacement is found. Before leaving for Millipore, a Billerica, Mass.-based biosciences company, Madaus chaired AdvaMed's In Vitro Diagnostic sector...
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.